Adial Pharmaceuticals, Inc.(ADIL)
Pharmaceuticals
CNS / Psychiatry Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-16 | Coastlands Capital LP 10% Owner | Purchase | +3,233 | +0.84%388,308 | $2.69 | $8,691 | View SEC filing | |
| 2026-07-13 | Coastlands Capital LP 10% Owner | Purchase | +11,753 | +3.15%385,075 | $2.78 | $32,638 | View SEC filing | |
| 2026-07-01 | Coastlands Capital LP 10% Owner | Purchase | +25,000 | +7.18%373,322 | $2.60 | $65,000 | View SEC filing | |
| 2026-06-16 | Young Wendy B. Director | Purchase | +36,378 | +100.00%36,378 | $2.75 | $99,999 | View SEC filing | |
| 2023-10-03 | Schuyler Kevin Director | Purchase | +700 | +11.89%6,589 | $2.74 | $1,918 | View SEC filing | |
| 2022-01-03 | Newman James W. Jr. Director | Purchase | +25,000 | +31.30%104,865 | $2.69 | $67,300 | View SEC filing | |
| 2021-12-01 | Stilley William B. III Chief Executive Officer | Purchase | +20,600 | +2.25%937,646 | $2.67 | $55,071 | View SEC filing | |
| 2021-11-30 | Newman James W. Jr. Director | Purchase | +10,000 | +40.86%34,475 | $2.85 | $28,500 | View SEC filing | |
| 2021-10-06 | Johnson Bankole A. Chief Medical Officer | Sale | -200,000 | -57.43%148,246 | N/A | N/A | View SEC filing | |
| 2021-04-08 | Johnson Bankole A. Chief Medical Officer | Sale | -150,000 | -21.48%548,336 | $2.50 | $375,000 | View SEC filing | |
| 2020-11-25 | Schuyler Kevin Director | Purchase | +180,000 | +80.72%402,990 | N/A | N/A | View SEC filing | |
| 2020-08-24 | Johnson Bankole A. Chief Medical Officer | Sale | -350,000 | -99.70%1,055 | $1.21 | $423,500 | View SEC filing | |
| 2020-03-30 | Newman James W. Jr. Director | Purchase | +19,644 | +84.35%42,932 | $1.36 | $26,769 | View SEC filing | |
| 2020-03-27 | Stilley William B. III Chief Executive Officer | Purchase | +25,000 | +3.62%715,937 | $1.30 | $32,552 | View SEC filing | |
| 2019-12-13 | Johnson Bankole A. Chief Medical Officer | Sale | -150,000 | -17.68%698,336 | $1.00 | $150,000 | View SEC filing | |
| 2019-04-01 | Johnson Bankole A. Chief Medical Officer | Purchase | +73,100 | +26.60%347,868 | $3.29 | $240,609 | View SEC filing | |
| 2018-08-02 | Stilley William B. III Chief Executive Officer | Purchase | +160,000 | +31.19%673,027 | N/A | N/A | View SEC filing | |
| 2018-08-02 | Schuyler Kevin Director | Purchase | +180,000 | +39.49%635,851 | N/A | N/A | View SEC filing | |
| 2018-08-02 | Newman James W. Jr. Director | Purchase | +40,000 | +17.21%272,419 | N/A | N/A | View SEC filing | |
| 2018-08-02 | Johnson Bankole A. Director, 10% Owner | Purchase | +2,800 | +1.67%170,714 | N/A | N/A | View SEC filing | |
| 2018-08-02 | Goodman Tony Director | Purchase | +14,000 | +797.72%15,755 | N/A | N/A | View SEC filing | |
| 2018-08-02 | Gilliland Robertson H. Director | Purchase | +57,931 | +30.60%247,276.34 | N/A | N/A | View SEC filing |
1-22 of 22